<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33772006</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>26</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>TDP-43 and PINK1 mediate CHCHD10<sup>S59L</sup> mutation-induced defects in Drosophila and in vitro.</ArticleTitle><Pagination><StartPage>1924</StartPage><MedlinePgn>1924</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1924</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-021-22145-9</ELocationID><Abstract><AbstractText>Mutations in coiled-coil-helix-coiled-coil-helix domain containing 10 (CHCHD10) can cause amyotrophic lateral sclerosis and frontotemporal dementia (ALS-FTD). However, the underlying mechanisms are unclear. Here, we generate CHCH10<sup>S59L</sup>-mutant Drosophila melanogaster and HeLa cell lines to model CHCHD10-associated ALS-FTD. The CHCHD10<sup>S59L</sup> mutation results in cell toxicity in several tissues and mitochondrial defects. CHCHD10<sup>S59L</sup> independently affects the TDP-43 and PINK1 pathways. CHCHD10<sup>S59L</sup> expression increases TDP-43 insolubility and mitochondrial translocation. Blocking TDP-43 mitochondrial translocation with a peptide inhibitor reduced CHCHD10<sup>S59L</sup>-mediated toxicity. While genetic and pharmacological modulation of PINK1 expression and activity of its substrates rescues and mitigates the CHCHD10<sup>S59L</sup>-induced phenotypes and mitochondrial defects, respectively, in both Drosophila and HeLa cells. Our findings suggest that CHCHD10<sup>S59L</sup>-induced TDP-43 mitochondrial translocation and chronic activation of PINK1-mediated pathways result in dominant toxicity, providing a mechanistic insight into the CHCHD10 mutations associated with ALS-FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Baek</LastName><ForeName>Minwoo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Choe</LastName><ForeName>Yun-Jeong</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bannwarth</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Inserm U1081, CNRS UMR7284, IRCAN, Universit&#xe9; C&#xf4;te d'Azur, CHU de Nice, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>JiHye</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maitra</LastName><ForeName>Swati</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dorn</LastName><ForeName>Gerald W</ForeName><Initials>GW</Initials><Suffix>2nd</Suffix><AffiliationInfo><Affiliation>Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taylor</LastName><ForeName>J Paul</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Howard Hughes Medical Institute and Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paquis-Flucklinger</LastName><ForeName>Veronique</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Inserm U1081, CNRS UMR7284, IRCAN, Universit&#xe9; C&#xf4;te d'Azur, CHU de Nice, Nice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Nam Chul</ForeName><Initials>NC</Initials><Identifier Source="ORCID">0000-0003-1332-3071</Identifier><AffiliationInfo><Affiliation>Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy, University of Minnesota, Duluth, MN, USA. kimn@umn.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 HL135736</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R56 NS112296</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>HHMI</Acronym><Agency>Howard Hughes Medical Institute</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C554426">CHCHD10 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D029721">Drosophila Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D024101">Mitochondrial Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000589036">TBPH protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="C534484">PINK1 protein, Drosophila</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D017346">Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Nat Commun. 2021 May 20;12(1):3165</RefSource><PMID Version="1">34016983</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D030801" MajorTopicYN="N">Animals, Genetically Modified</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029721" MajorTopicYN="N">Drosophila Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024101" MajorTopicYN="N">Mitochondrial Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017346" MajorTopicYN="N">Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017386" MajorTopicYN="N">Sequence Homology, Amino Acid</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>G.W.D. is the scientific founder of Mitochondria in Motion, Inc., which has license from WUSTL and is commercializing small-molecule mitofusin agonists for the treatment of neurodegenerative diseases. The remaining authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>27</Day><Hour>5</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33772006</ArticleId><ArticleId IdType="pmc">PMC7997989</ArticleId><ArticleId IdType="doi">10.1038/s41467-021-22145-9</ArticleId><ArticleId IdType="pii">10.1038/s41467-021-22145-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bannwarth S, et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain. 2014;137:2329&#x2013;2345.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou ZD, Saw WT, Tan EK. Mitochondrial CHCHD-containing proteins: physiologic functions and link with neurodegenerative diseases. Mol. Neurobiol. 2017;54:5534&#x2013;5546.</Citation><ArticleIdList><ArticleId IdType="pubmed">27631878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R, et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front. Neurosci. 2019;13:1&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis. Brain. 2014;137:e311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4240285</ArticleId><ArticleId IdType="pubmed">25261972</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller K, et al. Two novel mutations in conserved codons indicate that CHCHD10 is a gene associated with motor neuron disease. Brain. 2014;137:e309.</Citation><ArticleIdList><ArticleId IdType="pubmed">25113787</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, et al. Mutation analysis of CHCHD10 in different neurodegenerative diseases. Brain. 2015;138:e380.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4547051</ArticleId><ArticleId IdType="pubmed">25833818</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rheenen W, Diekstra FP, Van Den Berg LH, Veldink JH. Are CHCHD10 mutations indeed associated with familial amyotrophic lateral sclerosis? Brain. 2014;137:e313.</Citation><ArticleIdList><ArticleId IdType="pubmed">25348631</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, et al. CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2015;36:1767.e3&#x2013;1767.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4380794</ArticleId><ArticleId IdType="pubmed">25726362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ronchi D, et al. CHCHD10 mutations in Italian patients with sporadic amyotrophic lateral sclerosis. Brain. 2015;138:e372.</Citation><ArticleIdList><ArticleId IdType="pubmed">25576308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaussenot A, et al. Screening of CHCHD10 in a French cohort confirms the involvement of this gene in frontotemporal dementia with amyotrophic lateral sclerosis patients. Neurobiol. Aging. 2014;35:2884.e1&#x2013;2884.e4.</Citation><ArticleIdList><ArticleId IdType="pubmed">25155093</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, et al. CHCHD 10 mutations promote loss of mitochondrial cristae junctions with impaired mitochondrial genome maintenance and inhibition of apoptosis. EMBO Mol. Med. 2016;8:58&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4718158</ArticleId><ArticleId IdType="pubmed">26666268</ArticleId></ArticleIdList></Reference><Reference><Citation>Marroquin N, et al. Screening for CHCHD10 mutations in a large cohort of sporadic ALS patients: no evidence for pathogenicity of the p.P34S variant. Brain. 2016;139:e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5963426</ArticleId><ArticleId IdType="pubmed">26362909</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong CH, et al. The CHCHD10 P34S variant is not associated with ALS in a UK cohort of familial and sporadic patients. Neurobiol. Aging. 2015;36:2908.e17&#x2013;2908.e18.</Citation><ArticleIdList><ArticleId IdType="pubmed">26344877</ArticleId></ArticleIdList></Reference><Reference><Citation>Ajroud-Driss S, et al. Mutation in the novel nuclear-encoded mitochondrial protein CHCHD10 in a family with autosomal dominant mitochondrial myopathy. Neurogenetics. 2014;16:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4796476</ArticleId><ArticleId IdType="pubmed">25193783</ArticleId></ArticleIdList></Reference><Reference><Citation>Penttil&#xe4; S, et al. Late onset spinal motor neuronopathy is caused by mutation in CHCHD10. Ann. Neurol. 2015;77:163&#x2013;172.</Citation><ArticleIdList><ArticleId IdType="pubmed">25428574</ArticleId></ArticleIdList></Reference><Reference><Citation>Auranen M, et al. CHCHD10 variant p.(Gly66Val) causes axonal Charcot-Marie-Tooth disease. Neurol. Genet. 2015;1:e1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4821082</ArticleId><ArticleId IdType="pubmed">27066538</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts GDJ, et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat. Genet. 2004;36:377&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderek J, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am. J. Hum. Genet. 2009;84:511&#x2013;518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2667977</ArticleId><ArticleId IdType="pubmed">19344878</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JAA, et al. Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat. Commun. 2017;8:1&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467170</ArticleId><ArticleId IdType="pubmed">28585542</ArticleId></ArticleIdList></Reference><Reference><Citation>Brockmann SJ, et al. CHCHD10 mutations p. R15L and p. G66V cause motoneuron disease by haploinsufficiency. Hum. Mol. Genet. 2018;27:706&#x2013;715.</Citation><ArticleIdList><ArticleId IdType="pubmed">29315381</ArticleId></ArticleIdList></Reference><Reference><Citation>Straub IR, et al. Loss of CHCHD10-CHCHD2 complexes required for respiration underlies the pathogenicity of a CHCHD10 mutation in ALS. Hum. Mol. Genet. 2018;27:178&#x2013;189.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886208</ArticleId><ArticleId IdType="pubmed">29121267</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, et al. Loss of MICOS complex integrity and mitochondrial damage, but not TDP-43 mitochondrial localisation, are likely associated with severity of CHCHD10-related diseases. Neurobiol. Dis. 2018;119:159&#x2013;171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7015038</ArticleId><ArticleId IdType="pubmed">30092269</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins CMJ, Jung C, Ding H, Xu Z. Mutant Cu, Zn superoxide dismutase that causes motoneuron degeneration is present in mitochondria in the CNS. J. Neurosci. 2002;22:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6758252</ArticleId><ArticleId IdType="pubmed">11886899</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattiazzi M, et al. Mutated human SOD1 causes dysfunction of oxidative phosphorylation in mitochondria of transgenic mice. J. Biol. Chem. 2002;277:29626&#x2013;29633.</Citation><ArticleIdList><ArticleId IdType="pubmed">12050154</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat. Med. 2016;22:869&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4974139</ArticleId><ArticleId IdType="pubmed">27348499</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, et al. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, et al. Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781&#x2013;795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum. Mol. Genet. 2014;23:1413&#x2013;1424.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3929084</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, Y. et al. An integrative approach to ortholog prediction for disease-focused and other functional studies. BMC Bioinformatics12, 357 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3179972</ArticleId><ArticleId IdType="pubmed">21880147</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallaro G. Genome-wide analysis of eukaryotic twin CX9C proteins. Mol. Biosyst. 2010;6:2459&#x2013;2470.</Citation><ArticleIdList><ArticleId IdType="pubmed">20922212</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer J, et al. Quantitative assessment of eye phenotypes for functional genetic studies using Drosophila melanogaster. G3 Genes Genomes Genet. 2016;6:1427&#x2013;1437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4856093</ArticleId><ArticleId IdType="pubmed">26994292</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble GP, Dolph PJ, Supattapone S. Interallelic transcriptional enhancement as an in vivo measure of transvection in Drosophila melanogaster. G3 Genes Genomes Genet. 2016;6:3139&#x2013;3148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5068936</ArticleId><ArticleId IdType="pubmed">27489208</ArticleId></ArticleIdList></Reference><Reference><Citation>Burstein SR, et al. In vitro and in vivo studies of the ALS-FTLD protein CHCHD10 reveal novel mitochondrial topology and protein interactions. Hum. Mol. Genet. 2018;27:160&#x2013;177.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886281</ArticleId><ArticleId IdType="pubmed">29112723</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, et al. CHCHD2 accumulates in distressed mitochondria and facilitates oligomerization of CHCHD10. Hum. Mol. Genet. 2018;27:3881&#x2013;3900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6216204</ArticleId><ArticleId IdType="pubmed">30084972</ArticleId></ArticleIdList></Reference><Reference><Citation>Prelich G. Gene overexpression: uses, mechanisms, and interpretation. Genetics. 2012;190:841&#x2013;854.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3296252</ArticleId><ArticleId IdType="pubmed">22419077</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng H, et al. Loss of Parkinson&#x2019;s disease-associated protein CHCHD2 affects mitochondrial crista structure and destabilizes cytochrome c. Nat. Commun. 2017;8:1&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467237</ArticleId><ArticleId IdType="pubmed">28589937</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IRA, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007.</Citation><ArticleIdList><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JC, Morton DB. Drosophila lines with mutant and wild type human TDP-43 replacing the endogenous gene reveals phosphorylation and ubiquitination in mutant lines in the absence of viability or lifespan defects. PLoS ONE. 2017;12:1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5501610</ArticleId><ArticleId IdType="pubmed">28686708</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan L, et al. Cytosolic proteostasis through importing of misfolded proteins into mitochondria. Nature. 2017;543:443&#x2013;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5793917</ArticleId><ArticleId IdType="pubmed">28241148</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang P, Yu T, Yoon Y. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death. Eur. J. Cell Biol. 2007;86:289&#x2013;302.</Citation><ArticleIdList><ArticleId IdType="pubmed">17532093</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin SM, Youle RJ. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy. 2013;9:1750&#x2013;1757.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4028334</ArticleId><ArticleId IdType="pubmed">24149988</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin SM, Youle RJ. PINK1-and Parkin-mediated mitophagy at a glance. J. Cell Sci. 2012;125:795&#x2013;799.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3656616</ArticleId><ArticleId IdType="pubmed">22448035</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim NC, et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron. 2013;78:65&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3683300</ArticleId><ArticleId IdType="pubmed">23498974</ArticleId></ArticleIdList></Reference><Reference><Citation>Koyano F, et al. Ubiquitin is phosphorylated by PINK1 to activate parkin. Nature. 2014;510:162&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">24784582</ArticleId></ArticleIdList></Reference><Reference><Citation>Gegg ME, et al. Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Hum. Mol. Genet. 2010;19:4861&#x2013;4870.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3583518</ArticleId><ArticleId IdType="pubmed">20871098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma P, Yun J, Deng H, Guo M. Atg1-mediated autophagy suppresses tissue degeneration in pink1/parkin mutants by promoting mitochondrial fission in Drosophila. Mol. Biol. Cell. 2018;29:3082&#x2013;3092.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6340213</ArticleId><ArticleId IdType="pubmed">30354903</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhide S, et al. Increasing autophagy and blocking Nrf2 suppress laminopathy-induced age-dependent cardiac dysfunction and shortened lifespan. Aging Cell. 2018;17:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5946079</ArticleId><ArticleId IdType="pubmed">29575479</ArticleId></ArticleIdList></Reference><Reference><Citation>Marceau K, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;57:742&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018156</ArticleId><ArticleId IdType="pubmed">26266977</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai PI, et al. PINK1 phosphorylates MIC60/Mitofilin to control structural plasticity of mitochondrial crista junctions. Mol. Cell. 2018;69:744&#x2013;756.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">29456190</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha AG, et al. MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science. 2018;360:336&#x2013;341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6109362</ArticleId><ArticleId IdType="pubmed">29674596</ArticleId></ArticleIdList></Reference><Reference><Citation>Freibaum BD, et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature. 2015;525:129&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4631399</ArticleId><ArticleId IdType="pubmed">26308899</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp, B. E., Pearson, R. B. &amp; House, C. M.Pseudosubstrate-based peptide inhibitors. Methods Enzymol.201, 287&#x2013;304 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1943770</ArticleId></ArticleIdList></Reference><Reference><Citation>Madeira F, et al. The EMBL-EBI search and sequence analysis tools APIs in 2019. Nucleic Acids Res. 2019;47:W636&#x2013;W641.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6602479</ArticleId><ArticleId IdType="pubmed">30976793</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek, M., Choe, Y.-J., Dorn, G., Taylor, J. P. &amp; Kim, N. C. Dominant toxicity of ALS&#x2013;FTD-associated CHCHD10 S59L is mediated by TDP-43 and PINK1. Preprint at bioRXiv10.1101/753558 (2019).</Citation></Reference><Reference><Citation>Anderson CJ, et al. ALS/FTD mutant CHCHD10 mice reveal a tissue-specific toxic gain-of-function and mitochondrial stress response. Acta Neuropathol. 2019;138:103&#x2013;121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6571048</ArticleId><ArticleId IdType="pubmed">30877432</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, et al. Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10 S59L/+ mouse. Acta Neuropathol. 2019;138:123&#x2013;145.</Citation><ArticleIdList><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, et al. PINK1 and Parkin are genetic modifiers for FUS-induced neurodegeneration. Hum. Mol. Genet. 2016;25:5059&#x2013;5068.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6078632</ArticleId><ArticleId IdType="pubmed">27794540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun, X. et al. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy. Cell Death Dis. 9, 953 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6148241</ArticleId><ArticleId IdType="pubmed">30237395</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo, G. M. et al. Parkin is a disease modifier in the mutant SOD 1 mouse model of ALS. EMBO Mol. Med. 10, e8888 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6180298</ArticleId><ArticleId IdType="pubmed">30126943</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu YT, et al. Loss of CHCHD2 and CHCHD10 activates OMA1 peptidase to disrupt mitochondrial cristae phenocopying patient mutations. Hum. Mol. Genet. 2020;29:1547&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7268789</ArticleId><ArticleId IdType="pubmed">32338760</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, T. et al. CHCHD10&#x2010;regulated OPA1&#x2010;mitofilin complex mediates TDP&#x2010;43&#x2010;induced mitochondrial phenotypes associated with frontotemporal dementia. FASEB J. 10.1096/fj.201903133rr, 1&#x2013;17 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7482311</ArticleId><ArticleId IdType="pubmed">32369233</ArticleId></ArticleIdList></Reference><Reference><Citation>Purandare N, Somayajulu M, H&#xfc;ttemann M, Grossman LI, Aras S. The cellular stress proteins CHCHD10 and MNRR1 (CHCHD2): partners in mitochondrial and nuclear function and dysfunction. J. Biol. Chem. 2018;293:6517&#x2013;6529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5925800</ArticleId><ArticleId IdType="pubmed">29540477</ArticleId></ArticleIdList></Reference><Reference><Citation>Day RN, Davidson MW. The fluorescent protein palette: tools for cellular imaging. Chem. Soc. Rev. 2009;38:2887&#x2013;2921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910338</ArticleId><ArticleId IdType="pubmed">19771335</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, C. et al. The C-terminal TDP-43 fragments have a high aggregation propensity and harm neurons by a dominant-negative mechanism. PLoS ONE5, e15878 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3013128</ArticleId><ArticleId IdType="pubmed">21209826</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabeya, Y. et al. LC3, a mammalian homolog of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J.22, 4577 (2003); erratum 19, 5720&#x2013;5728 (2000)..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC305793</ArticleId><ArticleId IdType="pubmed">11060023</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahreiss L, Menzies FM, Rubinsztein DC. The itinerary of autophagosomes: from peripheral formation to kiss-and-run fusion with lysosomes. Traffic. 2008;9:574&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2329914</ArticleId><ArticleId IdType="pubmed">18182013</ArticleId></ArticleIdList></Reference><Reference><Citation>Frank S, et al. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev. Cell. 2001;1:515&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">11703942</ArticleId></ArticleIdList></Reference><Reference><Citation>Karbowski M, et al. Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 2002;159:931&#x2013;938.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2173996</ArticleId><ArticleId IdType="pubmed">12499352</ArticleId></ArticleIdList></Reference><Reference><Citation>Narendra, D. P. et al. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol. 8, e1000298 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2811155</ArticleId><ArticleId IdType="pubmed">20126261</ArticleId></ArticleIdList></Reference><Reference><Citation>Falc&#xf3;n-P&#xe9;rez JM, Nazarian R, Sabatti C, Dell&#x2019;Angelica EC. Distribution and dynamics of Lamp1-containing endocytic organelles in fibroblasts deficient in BLOC-3. J. Cell Sci. 2005;118:5243&#x2013;5255.</Citation><ArticleIdList><ArticleId IdType="pubmed">16249233</ArticleId></ArticleIdList></Reference><Reference><Citation>Valente AJ, Maddalena LA, Robb EL, Moradi F, Stuart JA. A simple ImageJ macro tool for analyzing mitochondrial network morphology in mammalian cell culture. Acta Histochem. 2017;119:315&#x2013;326.</Citation><ArticleIdList><ArticleId IdType="pubmed">28314612</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg S, et al. Ilastik: Interactive Machine Learning for (Bio)Image Analysis. Nat. Methods. 2019;16:1226&#x2013;1232.</Citation><ArticleIdList><ArticleId IdType="pubmed">31570887</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>